Dr. Benjamin Schwartz is now a full member of the American Academy of Implant Dentistry
The AAID allows Dr. Schwartz to stay current with all the latest technology and innovations in implant dentistry. The American Academy of Implant Dentistry is the source for
comprehensive information about what is happening in the profession and
the industry supporting implant dentistry.
Find Us On FaceBook!
ProDent NY is now on FaceBook!
We will be moving January 1st, 2011!
Dr. Schwartz is proud to announce the opening of our brand new dental office! The new office is located just around the corner between 36 and 37 streets, directly on Madison Avenue. The address is:
220 Madison Avenue, Office B - See Map
We are very excited to welcome all patients to our new, state of the art, ultra-comfortable dental office. Be on the lookout for mailings and information regarding the new office!
Dr. Benjamin Schwartz DDS publishes new articles.
Dr. Schwartz has just published two new articles regarding Invisalign treatment. As a leader in the dental field utilizing Invisalign, he was chosen to author these articles to assist other dentists. One publication was featured in England, printed in the United Kingdom Dental Tribune. The second article was published by Dental Learning, utilizing a peer reviewed system. Congratulations to Dr. Schwartz on this outstanding accomplishment.
Laughing Gas Now Available!
At ProDent NY, we are now pleased to offer our patients laughing gas (IE; Nitrous Oxide) to help make their dental appointments more relaxing.
Nitrous oxide allows you to enjoy your visits more, since it reduces the anxiety you may have of the dental procedure being performed. You feel relaxed and comfortable, while still being awake and conscious.
Ask about it next time you come in!
OraVerse
Dr. Benjamin Schwartz will begin offering OraVerse, an anesthesia reversal agent, in his practice this month.
OraVerse is the only local anesthesia reversal agent that enables patients to quickly return to normal function and sensation after routine dental procedures.
OraVerse has been proven to reverse anesthesia of the tongue and lip and its related side effects, which include prolonged numbness and decreased function while the anesthesia wears off, he said.
It’s no secret that many people fear dental procedures because they are afraid the procedure will be painful. Local anesthetic helps ensure patients are numb and comfortable throughout the procedure.
“Although patients welcome the anesthesia because they don’t want to be in pain, many of them don’t look forward to the lingering numbness that occurs after a local anesthetic is used during a dental procedure,” Dr Schwartz said. “Now patients can be completely anesthetized during their procedure and at the end of the appointment, we can administer OraVerse, which cuts the time of being numb in half.”
It enables people to return to work or simply get on with their day without lacking sensation in and around the area of the dental procedure, he said.
The U.S. Food and Drug Administration approved OraVerse for use in children and adults in October. Novalar Pharmaceuticals, Inc. is the dental specialty pharmaceutical company that developed the product. The company unveiled OraVerse during the 144th Chicago Dental Society Midwinter Meeting, which was held Feb. 26 through March 1 at McCormick Place. They began marketing its use in May.
The FDA has deemed OraVerse as an effective, safe product for adults and children who are at least six years old and weigh a minimum of 33 pounds.
Phentolamine mesylate is the active ingredient in OraVerse, and it is a drug that has been used in other medical applications for the past 50 years. OraVerse is administered in the site and in the same fashion as local anesthetic.